ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES reports a Return on Equity (ROE) of 0.00%.

What is ZYBT's dividend yield?

ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES offers a dividend yield of 0.00%.

What is ZYBT's Deepscope Quality Score?

Deepscope rates ZYBT's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ZYBT?

Deepscope's AI Timing Score for ZYBT is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ZYBT belong to?

ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

ZYBT (NASDAQ) Stock Analysis | ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-02 | FS: 2026-03-31)

ZYBT

ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES

USD 0.79

-0.06 (-6.93%) Day Change

Watchlist Portfolio Compare Chart

0.26

D/E

0.0%

ROE

0.0%

ROA

0.00%

Div Yield

Data partially updated

ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.79 Price -0.06 (-6.93%) Day Change	NEWS SCORE: 96

ZYBT, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.79
PBV / Sector	0.13 / 2.74 GREAT
Earning Per Share	N/A

PE / Sector	N/A / 23.29
PEG or PE/Growth / Sector	N/A / 0.11
Average 1M Daily Value	0.06 M GREAT
Average 1W Daily Value	5229.558100000000

Timing Factors

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 15.98
NPM Average (%) / Sector	-5.27 / -16.38
NPM Change Average (%) / Sector	-316.12 / 113.39
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	N/A / 8.16
ROA Average (%) / Sector	0.40 / 2.38
ROA Change Average (%) / Sector	-296.93 / 108.63
ROE (%) / Sector	N/A / -0.19
ROE Average (%) / Sector	0.84 / 7.40
ROE Change Average (%) / Sector	-297.83 / 371.95
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.53
Dividend Average (%) / Sector	N/A / 3.07
Dividend Change Average (%) / Sector	N/A / 14.48

Registration Details

Analyze Date	2026-06-03 09:10:47
Symbol	ZYBT
Name	ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	47.39 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	40.23 / 9,635.82

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: No.1 Lianmeng Road, Jilin, China

Phone: 86 432 6304 7008

Website: https://www.jlzybio.com

Employees: 269

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.